Panel discussion

The future of single-use technology in bioprocessing

Single-use technology is a rapidly growing field. More and more bioprocessing companies are using single-use components and more and more suppliers are working on smart new single-use technologies. The annual growth of the Single-Use Event is good proof of this.

It is a good moment to realize how far we have come in this technology. What are the challenges that developers and end-users of single-use technologies face today? For example in the field of sustainability? What are new trends in single-use technology?

We have organized a discussion panel at the Single-Use Event 2024 in which experts will discuss these issues.

Meet the panelists

Gerben Zijlstra

Process Technology Manager at Sartorius Stedim Biotech

Gerben is a regular speaker on process intensification (PI), process integration and continuous biomanufacturing. He has worked for more than 25 years in the BioPharma Industry amongst others in the CDMO business at Patheon developing commercial Bio-therapeutics, as well as Process Intensification projects in Single Use bioreactors. Currently he holds a position as Process Technology Manager at Sartorius-Stedim Biotech, working with external partners to further improve the Sartorius PI technology portfolio for the benefit of the BioPharma industry.

René Matt

Key Account Manager at Hamilton Bonaduz

Mr. René Matt is senior account manager for Single use products and responsible for the integration process of all Hamilton SU Sensor solutions to the main bioreactor manufacturers and partners worldwide.

Jeroen van de Laar

Process Specialist at Batavia Biomanufacturing

Jeroen van de Laar has 25 years all-round experience and performance in biotech and pharma, development, people management, upstream/downstream industrial processes, production organization, lean six sigma, quality and regulatory compliance and validation, audits, connection with the markets.

Lennek de Winter

Head of CLD & USP at Polpharma Biologics

Lenneke de Winter is currently Head of CLD and USP at Polpharma Biologics (Utrecht). Lenneke de Winter brings experience from previous roles at Bioceros, EPIRUS Biopharmaceuticals and Wageningen University.